Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Luminescence ; 37(12): 2129-2138, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36327119

RESUMEN

In this article bacterial carbonate mineralization treatments are proposed as a novel strategy for decayed fossils and palaeontological heritage conservation; specifically, by means of inoculation of Myxococcus xanthus, a bacterium of proven effectiveness in ornamental stone bioconsolidation. Bioconsolidation treatments can be very effective, stable, nontoxic, environmentally friendly, and chemically compatible with fossil heritage. The method reproduces what nature has been doing for millennia with fossils that have been permineralized by bacterial calcium carbonate precipitation. There is, however, some concern that bacterial inoculation could lead to the growth of undesirable microbiota, which could subsequently damage the fossil substrate. Because of this, the use of bacteria on heritage items must be meticulously monitored and analysis strategies should be carried out to detect bacteria viability during and after treatments. For this purpose, adenosine triphosphate assay is proposed in this article as a fast, affordable, portable, and easy-to-use system for conservators. as ATP assay results are relative and difficult to relate to colony forming unit, this study aims to improve their applicability by examining the correlation between ATP analysis and total viable bacteria count in the specific case of M. xanthus. This research provides reference and correlatable data to obtain an approximate estimation of M. xanthus viable bacterial colonies based on relative light unit data.


Asunto(s)
Adenosina Trifosfato , Myxococcus xanthus , Carbonato de Calcio , Células Madre
2.
Tumour Biol ; 35(3): 1945-53, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24114015

RESUMEN

Breast cancer screening programmes seem to bring about significant benefits, including decreased mortality, although they may also have some drawbacks such as false-negative and false-positive results. This study aims to compare the clinical outcome of a group of patients undergoing a breast cancer screening programme with that of a synchronous non-screened group of patients matched for age and follow-up period. We studied basic characteristics of epidemiology, immunohistochemistry, loco-regional relapse, distant metastases, disease-free interval and overall and specific mortality. We compared 510 patients in the screened group with 394 non-screened patients, along the period of 2002-2012. Screening was applied on a target population of 49,847 and was based on double-projection, double-read mammograms. Two years were allowed per round. Overall participation for the five rounds considered was 75.2%, with 86.5% coverage, and a total cumulative population of 123,445. The non-participant women amounted 40,794. Tumour detection rate for the screened women was 3.8 per thousand (475/123,445), while the corresponding rate for non-participants was 9.4 per thousand (382/40,797). Incidence of luminal A subtype was 15% higher in screened than that in non-screened patients (95% confidence interval (CI) 8-22%). Conversely, the triple-negative subtype was 6% higher in the non-screened group (95% CI 2-10%). Incidence of breast conservative treatments and sentinel node biopsies was significantly higher in the screened group. Overall mortality was 2.6 times higher in non-screened than that in screened group (95% CI 1.2-5.6) After 10 years of experience with our own screening programme, we believe that included patients receive a benefit versus comparable non-screened breast cancer patients, with acceptable benefit-risk relation.


Asunto(s)
Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Detección Precoz del Cáncer/estadística & datos numéricos , Mamografía/estadística & datos numéricos , Anciano , Femenino , Humanos , Estimación de Kaplan-Meier , Persona de Mediana Edad , Recurrencia , Factores de Tiempo
3.
Heliyon ; 9(7): e17597, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37449105

RESUMEN

This research paper proposes Microbially Induced Calcium Carbonate Precipitation (MICP) as an innovative approach for palaeontological heritage conservation, specifically on deteriorated carbonate fossils. Due to its efficiency in bioconsolidation of carbonate ornamental rocks, Myxococcus xanthus inoculation on carbonate fossils was studied in this research. Treatment was tested on nine fossil samples from decontextualized fragments of Cheirogaster richardi specimens (Can Mata site, Hostalets de Pierola, Catalonia, Spain). The main objective was to evaluate whether treatment with Myxococcus xanthus improved fossil surface cohesion and hardness and mechanical strength without significant physicochemical and aesthetic changes to the surface. Chemical compatibility of the treatment, penetration capacity and absence of noticeable changes in substrate porosity were considered as important issues to be evaluated. Samples were analysed, before and after treatment, by scanning electron microscopy, weight control, spectrophotometry, X-ray diffraction analysis, water absorption analysis, pH and conductivity control, Vickers microindentation and tape test. Results show that hardness increases by a factor of almost two. Cohesion also increases and surface disaggregated particles are bonded together by a calcium carbonate micrometric layer with no noticeable changes in surface roughness. Colour and gloss variations are negligible, and pH, conductivity and weight hardly change. Slight changes in porosity were observed but without total pore clogging. To sum up, results indicate that Myxococcus xanthus biomineralisation is an effective consolidation treatment for carbonate fossils and highly compatible with carbonate substrates. Furthermore, bacterial precipitation of calcium carbonate is a safe and eco-friendly consolidation treatment.

4.
Rev Esp Med Nucl ; 29(6): 308-9, 2010.
Artículo en Español | MEDLINE | ID: mdl-20880609

RESUMEN

Allergic reactions to albumin nanocolloid are rare. Most of them are not potentially serious and in some cases treatment with antihistamines may be needed. We present a case of a patient with grade II right breast ductal carcinoma, in whom a lymphoscintigraphy was performed for sentinel lymph node detection. She had a type I hypersensitivity reaction following the administration of (99m)Tc-albumin nanocolloid, which abated spontaneously without subsequent sequels.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Carcinoma Ductal de Mama/diagnóstico por imagen , Carcinoma Ductal de Mama/secundario , Hipersensibilidad Inmediata/etiología , Metástasis Linfática/diagnóstico por imagen , Radiofármacos/efectos adversos , Biopsia del Ganglio Linfático Centinela , Agregado de Albúmina Marcado con Tecnecio Tc 99m/efectos adversos , Anciano de 80 o más Años , Femenino , Humanos , Escisión del Ganglio Linfático , Cintigrafía
5.
Radiat Oncol ; 15(1): 28, 2020 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-32005123

RESUMEN

INTRODUCTION: Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy. METHODS: Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact. RESULTS: Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p <  0.001). CONCLUSIONS: The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.


Asunto(s)
Adenocarcinoma/radioterapia , Carcinoma de Células Escamosas/radioterapia , Atención a la Salud/normas , Terapia Neoadyuvante/mortalidad , Mejoramiento de la Calidad , Radioterapia Adyuvante/mortalidad , Neoplasias del Recto/radioterapia , Adenocarcinoma/patología , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Neoplasias del Recto/patología , Tasa de Supervivencia
6.
Transl Oncol ; 11(3): 794-799, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29704788

RESUMEN

BACKGROUND: The therapeutic approach to cancer is complex and multidisciplinary. Radiotherapy is among the essential treatments, whether used alone or in conjunction with other therapies. This study reports a clinical audit of the radiotherapy process to assess the process of care, evaluate adherence to agreed protocols and measure the variability to improve therapeutic quality for rectal cancer. METHODS: Multicentre retrospective cohort study in a representative sample of patients diagnosed with rectal cancer in the Institut Català d'Oncologia, a comprehensive cancer centre with three different settings. We developed a set of indicators to assess the key areas of the radiotherapy process. The clinical audit consisted of a review of a random sample of 40 clinical histories for each centre. RESULTS: The demographic profile, histology and staging of patients were similar between centres. The MRI reports did not include the distance from tumour to mesorectal fascia (rCRM) in 38.3% of the cases. 96.7% of patients received the planned dose, and 57.4% received it at the planned time. Surgery followed neoadjuvant treatment in 96.7% of the patients. Among this group, postoperative CRM was recorded in 65.5% of the cases and was negative in 93.4% of these. With regard to the 34.5% (n = 40) of cases where no CRM value was stated, there were differences between the centres. Mean follow-up was 3.4 (SD 0.6) years, and overall survival at four years was 81.7%. CONCLUSIONS: The audit revealed a suboptimal degree of adherence to clinical practice guidelines. Significant variability between centres exists from a clinical perspective but especially with regard to organization and process.

7.
Rev Neurol ; 64(s01): S73-S77, 2017 Feb 24.
Artículo en Español | MEDLINE | ID: mdl-28256690

RESUMEN

Today, the fact that sensory integration difficulties with a neurological basis exist and that they seriously condition the development of those individuals who suffer from them is widely accepted and acknowledged as being obvious by the vast majority of professionals working in the field of community healthcare. However, less is known and there is more controversy about effective treatments that can be applied to them. This is because many professionals criticise the fact that there is not enough scientific evidence to prove, both quantitatively and empirically, the outcomes of the interventions implemented as alternatives to pharmacological therapy. Consequently, when the symptoms and repercussions on the quality of life deriving from a distorted sensory integration are really disabling for the person, pharmacological treatment is used as the only possible approach, with the side effects that this entails. The reason for this is largely the fact that little is known about other effective therapeutic approaches, such as occupational therapy based on sensory integration.


TITLE: Integracion sensorial: beneficios y efectividad del abordaje terapeutico en los trastornos del procesamiento sensorial.En la actualidad, el hecho de que existen dificultades de integracion sensorial de base neurologica y que estas condicionan gravemente el desarrollo de las personas que las sufren, esta aceptado y reconocido como evidente por la gran mayoria de profesionales del campo sociosanitario. No obstante, en cuanto a tratamientos efectivos para abordarlas, hay mas controversia y desconocimiento, ya que existe la critica generalizada de que las intervenciones alternativas a la farmacologica no constan con la suficiente evidencia cientifica que demuestre de forma cuantitativa y empirica los resultados obtenidos a traves de ella. Consecuentemente, cuando los sintomas y repercusion en la calidad de vida derivados de una integracion sensorial distorsionada son realmente limitantes para la persona, se acaba recurriendo al tratamiento farmacologico como unico abordaje posible, con los efectos secundarios que ello conlleva, debido al desconocimiento de enfoques terapeuticos efectivos, como la terapia ocupacional basada en el enfoque de la integracion sensorial.


Asunto(s)
Trastornos de la Sensación/terapia , Niño , Humanos , Sensación , Trastornos de la Sensación/fisiopatología , Resultado del Tratamiento
8.
Gac Sanit ; 20(2): 91-9, 2006.
Artículo en Español | MEDLINE | ID: mdl-16753084

RESUMEN

OBJECTIVE: To ascertain why people attend hospital emergency departments (ED) for low complexity health problems. METHOD: A phenomenological, interactionist, qualitative study was performed. A theoretical sample that selected one urban and one rural area from Catalonia (Spain) was designed. In each setting, persons (n = 36) who had used the ED or a primary care emergency service 1 month before the beginning of the study were chosen. Data were obtained through 8 focus groups. An interpretative content analysis was performed, and emergent categories were constructed through research triangulation. RESULTS: Five categories emerged: symptoms, whether or not self-diagnosis was involved, perception of needs, awareness of the health services available, and the overall context of the person. Symptoms generated feelings of failing health and thus initiated care seeking. Self-diagnosis determined perceived need and the type of care sought. People contrasted their self-perception of need with their own opinion about the health services available. The decision to go to one or other service was made as a result of this contrast, but the individual's family, work, and social situations also played a part. Informants were more familiar with the service provided by the ED than with that provided by primary care. Time consumption also figured heavily in decision making. CONCLUSIONS: The presence or absence of self-diagnosis is a determining factor in attendance at EDs. Other factors that influence demand are the level of awareness of the health services available, previous experiences, and the life situation of the individual.


Asunto(s)
Servicio de Urgencia en Hospital/estadística & datos numéricos , Aceptación de la Atención de Salud , Humanos , Aceptación de la Atención de Salud/psicología , España
9.
Clin Transl Oncol ; 18(11): 1098-1105, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26920150

RESUMEN

INTRODUCTION: Until recently, completion ALND has been considered the standard of care after a positive SN in breast cancer patients. However, most patients will not display further axillary involvement. The Tenon score is a simple nomogram that can be used intraoperatively to avoid completion ALND in low-risk patients. We aimed at validating the Tenon score on a SN-positive patient sample that had been preoperatively selected using axillary US examination. PATIENTS AND METHOD: We used a retrospective analysis of our bicentric database that included 246 breast cancer patients with a positive SN. We calculated sensitivity, specificity, as well as positive and negative predictive values for each cut-off point. ROCs were constructed and corresponding AUC values were calculated as a measure of discriminative capacity. RESULTS: At least one non-SN was positive in 52 patients (21.1 %). 118 patients (48 %) had a score up to 5. Among them, three had at least one positive non-SN. NPV was 97.5 %. Using that threshold, the ROCs analysis showed an AUC of 0.822 (95 % CI 0.764-0.880). CONCLUSION: Use of preoperative axillary US examination led to a modification of the proposed Tenon cut-off value from 3.5 to 5 to attain good predictive power for non-SN status. Straightforward intraoperative use of the Tenon score may be considered an advantage over other available nomograms.


Asunto(s)
Neoplasias de la Mama/patología , Escisión del Ganglio Linfático/métodos , Estadificación de Neoplasias/métodos , Adulto , Anciano , Anciano de 80 o más Años , Axila , Neoplasias de la Mama/cirugía , Femenino , Humanos , Metástasis Linfática , Persona de Mediana Edad , Nomogramas , Estudios Retrospectivos , Biopsia del Ganglio Linfático Centinela
10.
Rev Neurol ; 41(3): 129-36, 2005.
Artículo en Español | MEDLINE | ID: mdl-16047294

RESUMEN

INTRODUCTION: People with Down syndrome have an early aging process, especially form their 40s. There is a significant average of them who initiate, from that age on, a progressive decline of their cognitive and functional abilities, due to a primary degenerative process Alzheimer's disease type. When assessing response to treatment with, pilot clinical trials on this population have demonstrated real benefits therapeutically. AIMS: To assess the efficacy and safety of a pharmacological treatment with donepezil over cognitive and behavioral disturbances on patients with Down syndrome older than 40 years, areas where family and professional educators of reference have observed cognitive and behavioral changes in comparison with their previous level of disability. PATIENTS AND METHODS: Patients have been selected from different institutions affiliated at the Catalan Foundation for the Down syndrome and by the Catalan Federation Pro Persons with Psychic Disability. Several deterioration, behavioral and functional assessment scales have been used, all of them validated into this population. RESULTS: The results of study demonstrated that donepezil slowed the progression of the cognitive dysfunction, especially during the first three months of treatment. This occurred for both cognitive and social-behavioral outcomes. CONCLUSIONS: Donepezil appears to be effective in the treatment of cognitive and behavioural disturbances associated with the progressive dementia syndrome in Down's. However, the sample sizes used in this, and all published studies are small and this emphasizes the need for a larger, multi-center trial to fully evaluate the nature and extent of the response of Down's syndrome patients to anticolinesterase therapy.


Asunto(s)
Inhibidores de la Colinesterasa/uso terapéutico , Demencia , Síndrome de Down , Indanos/uso terapéutico , Piperidinas/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/fisiología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/etiología , Enfermedad de Alzheimer/fisiopatología , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Demencia/tratamiento farmacológico , Demencia/etiología , Demencia/fisiopatología , Donepezilo , Síndrome de Down/complicaciones , Síndrome de Down/fisiopatología , Humanos , Persona de Mediana Edad , Pruebas Neuropsicológicas
11.
Rev Esp Cardiol ; 46(10): 626-32, 1993 Oct.
Artículo en Español | MEDLINE | ID: mdl-8234997

RESUMEN

INTRODUCTION AND OBJECTIVES: High blood pressure is a cardiovascular risk factor whose coincidence with other risk factors considerably increases the probability for coronary heart disease. This study investigates the prevalence of different risk factors in hypertensive subjects. METHODS: We studied 891 patients with high blood pressure in their first visit to a hospital hypertension unit between 1987 and 1991. We assessed their clinical evolution and the prevalence of obesity, smoking, alcohol consumption, elevated blood pressure, diabetes, sedentary lifestyle, left ventricular hypertrophy and family history of high blood pressure. RESULTS: Sixteen per cent of the hypertensive subjects related previous history of evolutive accident. Stroke was the most frequent one. Prevalences of cardiovascular risk factors were as follows: family history of high blood pressure 53%, sedentary lifestyle 52%, elevated blood cholesterol 37%, smoking 35%, obesity 33%, left ventricular hypertrophy 16%, alcohol consumption 13% and diabetes 11%. Obesity prevalence was twice as high in women than in men. Males had higher prevalence for left ventricular hypertrophy, smoking and alcohol consumption. Diabetes was more prevalent in hypertensive patients older than 50 years. Prevalence of high blood cholesterol was greater in the group of women older than 50 years. CONCLUSIONS: Hypertensive patients have high prevalences of other cardiovascular risk factors. Their treatment should be aimed to improving the individual profile of cardiovascular risk.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Hipertensión/epidemiología , Adulto , Factores de Edad , Anciano , Enfermedades Cardiovasculares/etiología , Distribución de Chi-Cuadrado , Femenino , Humanos , Hipertensión/complicaciones , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Factores Sexuales , España/epidemiología
12.
Rev Esp Cardiol ; 52(2): 139-41, 1999 Feb.
Artículo en Español | MEDLINE | ID: mdl-10073098

RESUMEN

We describe the rare association of angina at effort and presyncope in a young patient with an anomalous origin of left coronary artery and associated coronary spasm in the normal right coronary artery. The patient did well under calcium channel blocker therapy after seven years of follow-up, which is in contrast with the usual recommended management of these patients.


Asunto(s)
Angina de Pecho/etiología , Vasoespasmo Coronario/complicaciones , Anomalías de los Vasos Coronarios/complicaciones , Síncope/etiología , Adulto , Angina de Pecho/diagnóstico , Angina de Pecho/tratamiento farmacológico , Bloqueadores de los Canales de Calcio/uso terapéutico , Vasoespasmo Coronario/diagnóstico , Vasoespasmo Coronario/tratamiento farmacológico , Anomalías de los Vasos Coronarios/diagnóstico , Anomalías de los Vasos Coronarios/tratamiento farmacológico , Quimioterapia Combinada , Humanos , Masculino , Nifedipino/administración & dosificación , Esfuerzo Físico , Pronóstico , Seno Aórtico/anomalías , Síncope/diagnóstico , Síncope/tratamiento farmacológico , Verapamilo/administración & dosificación
13.
Rev Neurol ; 33(5): 471-6, 2001.
Artículo en Español | MEDLINE | ID: mdl-11727217

RESUMEN

INTRODUCTION: The amygdaloid body is a structure localized to the temporal lobe in mammals, formed by different nuclei and traditionally associated with the emotion system of the brain. Some investigators have suggested an alternative function for the amygdaloid body, considering it to be part of the system modulating memory. Much of the experimental data supports both functions. DEVELOPMENT: The relation of the amygdaloid body with the emotions has been based on the study of the conditioning of fear, by which an emotionally neutral stimulus can cause emotional reactions due to its temporal association with an adverse stimulus. It has been shown that the amygdaloid body is necessary for learning and expressing this conditioning, and is therefore involved in emotional learning. With regard to the relation of the amygdaloid body with the modulation of memory, one should point out the results which show that it is not always necessary for learning and memory, but is necessary for showing the modulating effects of different substances on memory. The amygdaloid body modulates the storage of memory in other regions of the brain, such as the caudate nucleus and the hippocampus. CONCLUSIONS: Current data suggests that the whole amygdaloid complex is not involved in the two functions. However, the lateral and central nuclei participate in emotional learning whilst the basolateral nucleus is especially involved in modulation of the memory when emotional activation occurs.


Asunto(s)
Afecto/fisiología , Amígdala del Cerebelo/fisiología , Humanos , Memoria/fisiología
15.
Breast ; 21(3): 366-73, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22487206

RESUMEN

As far as recent breast cancer molecular subtype classification is concerned, much work has dealt with clinical outcomes for triple negative and Her2 patients. Less is known about the course of patients in the remaining subtypes. Molecular classification based on immunohistochemistry is widely available and correlates well with genetic microarray assessment, but at a lower cost. The aim of our investigation was to correlate immunohistochemical subtypes of breast cancer with clinical characteristics and patient outcomes. Since 1998, 1167 patients operated for 1191 invasive breast tumours were included in our database. Patients were regularly followed up until March 2010. Disease-free survival, overall mortality, and breast cancer-specific mortality at 5 years were calculated for the cohort. 72% of tumours were ER+PR±HER2- group, 13% triple negative (ER-PR-HER2-), 10% ER+PR±HER2+ group, and 5% Her2 (ER-PR-HER2+). Cancer-specific survival was 94.2% for the ER+PR+HER2- subtype, 84.8% for the Her2 subtype, 83.3% for the ER+PR-HER2- subtype, and 78.6% for triple negatives. Distant metastases prevalence ranged from 7% to 22% across subtypes, increasing stepwise from ER+PR+HER2-, ER+PR+HER2+, ER+PR-HER2-, ER+PR-HER2+, ER-PR-HER2+ through triple negative. Small, low-grade tumours with low axillary burden were more likely to belong to the ER+PR±HER2- group. Conversely, larger high-grade tumours with significant axillary burden were more likely to belong to Her2 or triple negative groups. ER+PR±HER2- group patients with negative PR receptors performed more like Her2 or triple negative than like the rest of ER+PR±HER2± groups patients. Molecular classification of breast tumours based only on immunohistochemistry is quite useful on practical clinical grounds, as expected. ER+PR±HER2- group patients with negative PR receptors seem to be at high risk and deserve further consideration.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/clasificación , Neoplasias de la Mama/metabolismo , Receptor ErbB-2/metabolismo , Salud de la Mujer , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Análisis Multivariante , Metástasis de la Neoplasia , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , España/epidemiología , Análisis de Supervivencia , Resultado del Tratamiento , Adulto Joven
16.
Ultrasound Med Biol ; 37(1): 16-22, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21144955

RESUMEN

We assessed the diagnostic yield of axillary ultrasound, alone or in combination with fine-needle aspiration axillary biopsy and magnetic resonance imaging in patients with invasive breast carcinoma compared with final axillary histology by sentinel node biopsy or by axillary lymph node dissection. From January 2003 to March 2009, 520 axillary ultrasound examinations and 105 axillary magnetic resonance imaging studies were included. Compared with final axillary histology, ultrasound fine-needle aspiration showed positive predictive value of 87%, negative predictive value of 82%, sensitivity of 53% and specificity of 100%. In cases of negative ultrasound, the rate of positive nodes was 17% (micro-metastases excluded). Ultrasound examination of the axilla, combined with fine-needle aspiration as appropriate must be included in the preoperative work-up of patients considered for sentinel node biopsy to definitively establish such an indication while minimizing the risk of false-negative sentinel node. Axillary magnetic resonance imaging did not improve the preoperative work-up.


Asunto(s)
Axila/diagnóstico por imagen , Neoplasias de la Mama/diagnóstico por imagen , Metástasis Linfática/diagnóstico por imagen , Imagen por Resonancia Magnética , Axila/patología , Biopsia con Aguja Fina , Neoplasias de la Mama/patología , Neoplasias de la Mama/cirugía , Distribución de Chi-Cuadrado , Femenino , Humanos , Metástasis Linfática/patología , Persona de Mediana Edad , Invasividad Neoplásica , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Biopsia del Ganglio Linfático Centinela , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA